This study is recruiting. It focuses on depression and currently lists participation information in France.
This study is looking at whether À deux, c'est mieux (Better Together) Group Intervention can help people with severe mental illness. Participants take part in À deux, c'est mieux (Better Together) Group Intervention and complete follow-up assessments. Taking part may give some people access to À deux, c'est mieux (Better Together) Group Intervention, but direct benefit is not guaranteed.
The official record suggests in-person participation through a research setting, with sites including HDJ (Hôpital de Jour) in Épinay-sur-Seine and L'UNIRRE (Unité Référente de Réhabilitation) in Neuilly-sur-Marne. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it is evaluating À deux, c'est mieux (Better Together) Group Intervention in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in France.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Centre hospitalier de Ville-Evrard, France. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.